Latest Celgene Corporation Stories

CHICAGO, April 30, 2013 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Merck & Co. Inc. (NYSE:MRK), GlaxoSmithKline (NYSE:GSK), VIVUS Inc. (Nasdaq:VVUS), Santarus, Inc. (Nasdaq:SNTS) and Celgene Corporation (Nasdaq:CELG). (Logo:...

SAN DIEGO, April 12, 2013 /PRNewswire-USNewswire/ -- Robert J. Hugin, chairman and CEO of Celgene Corporation, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association's annual meeting. Also elected were Ian C. Read, president and CEO of Pfizer Inc, as chairman-elect of the PhRMA Board of Directors, and Kenneth C. Frazier, Chairman, President and CEO of Merck & Co, Inc., as Board treasurer. (Logo:...

LONDON, March 18, 2013 /PRNewswire/ -- The healthcare industry is evaluating the impact of President Obama's Affordable Care Act (ACA) on their businesses. While critics of the healthcare reform say that the ACA will result in higher costs for healthcare companies, supporters of the reform point out the long-term benefits to the industry which include players such as Amarin Corporation Plc (NASDAQ: AMRN), Celgene Corporation (NASDAQ: CELG), GlaxoSmithKline Plc (NYSE: GSK),...

NEW YORK, March 18, 2013 /PRNewswire/ -- Today, Wall Street Source announced new research reports highlighting Gilead Sciences, Inc. (NASDAQ: GILD), Celgene Corporation (NASDAQ: CELG), Sinovac Biotech Ltd. (NASDAQ: SVA), NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) and ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. Gilead Sciences,...

-- Partnership Employs Presage's Innovative Platform to Accelerate Identification of Novel Oncology Drug Combinations for Patients with Solid Tumors -- SEATTLE, March 5, 2013 /PRNewswire/ -- Presage Biosciences, a leader in discovering effective cancer drug combinations, today announced that it has entered into a strategic collaboration agreement with Celgene Corporation under which Presage and Celgene will take advantage of Presage's proprietary technology platform to identify novel...

MANHATTAN BEACH, Calif., Jan. 22, 2013 /PRNewswire/ -- The Pancreatic Cancer Action Network is pleased to announce that today Celgene Corporation (Celgene) reported that the combination of its chemotherapeutic drug ABRAXANE® with gemcitabine improved overall survival in patients with metastatic pancreatic cancer by nearly two months (8.5 months vs. 6.7 months) when compared with gemcitabine alone. According to Celgene, this combination also demonstrated a 59 percent increase in...

LONDON, January 14, 2013 /PRNewswire/ -- Although much has been made over pharmaceutical company profits tumbling due to loss of exclusivity for blockbuster drugs, companies in the biotechnology technology industry have been turning in strong quarterly earnings, and also have a number of exciting new products that are scheduled to soon hit the market. Companies like Dendreon Corporation (NASDAQ:DNDN), Sequenom Inc. (NASDAQ:SQNM) and Celgene Corporation (NASDAQ:CELG) have been...

HONG KONG, Jan. 9, 2013 /PRNewswire/ -- Insiderslab.com has issued insider trading reports and equity researchfor the following companies: Verizon (NYSE:VZ), Goldcorp (NYSE:GG), Celgene (NASDAQ:CELG), Alpha Natural Resources (NYSE:ANR), American International Group (NYSE:AIG), and AbbVie (NYSE:ABBV). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...

VANCOUVER, British Columbia, Nov. 13, 2012 /PRNewswire/ -- EarningForecast.com has issued consensus earnings forecast reports and equity research for the following companies: Gilead Sciences (NASDAQ:GILD), Citigroup (NYSE:C), Hewlett-Packard (NYSE:HPQ), Celgene (NASDAQ:CELG), JPMorgan (NYSE:JPM), and Sirius (NASDAQ:SIRI). (Logo: http://photos.prnewswire.com/prnh/20121030/HK02457LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to...

VANCOUVER, British Columbia, Nov. 13, 2012 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Citigroup (NYSE:C), Celgene (NASDAQ:CELG), QUALCOMM (NASDAQ:QCOM), Mylan (NASDAQ:MYL), Western Union (NYSE:WU), and Dow Chemical (NYSE:DOW). (Logo: http://photos.prnewswire.com/prnh/20121105/HK06856LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your...